Interactions between Schwann and olfactory ensheathing cells with a starch/polycaprolactone scaffold aimed at spinal cord injury repair by Silva, Nuno et al.
Interactions between Schwann and olfactory ensheathing cells with a
starch/polycaprolactone scaffold aimed at spinal cord injury repair
Nuno A. Silva,1,2,3 Rui A. Sousa,1,2 Ana O. Pires,2,3 Nuno Sousa,2,3
Anto´nio J. Salgado,2,3* Rui L. Reis1,2*
13B’s Research Group, Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European
Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909 Caldas das Taipas,
Guimara˜es, Portugal
2ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimara˜es, Portugal
3Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
Received 29 July 2011; revised 15 September 2011; accepted 26 September 2011
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jbm.a.33289
Abstract: Spinal cord injury (SCI) represents a major world
health problem. Therefore it is urgent to develop novel strat-
egies that can speciﬁcally target it. We have previously
shown that the implantation of starch-based scaffolds (SPCL)
aimed for spine stabilization on SCI animals leads to motor
skills improvements. Therefore, we hypothesize that the com-
bination of these scaffolds with relevant cell populations for
SCI repair will, most likely, lead to further improvements.
Therefore, in this work, the ability of SPCL scaffolds to sup-
port the 3D culture of olfactory ensheathing cells (OECs) and
Schwann cells (SCs) was studied and characterized. The
results demonstrate for the ﬁrst time that SPCL scaffolds
were able to support the growth and migration of OECs and
SCs. Moreover, the results indicate that two weeks of in vitro
culture is the ideal time to reach a high number of transplant-
able cells. Future work will focus on the spine stabilization of
SCI animals using SPCL scaffolds loaded with OECs or SCs
for SCI regeneration. VC 2011 Wiley Periodicals, Inc. J Biomed Mater
Res Part A: 00A: 000–000, 2011.
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INTRODUCTION
Motivated by the physical consequences of the World War
II, the era of cell transplantation began with the landmark
work of Georges Mathe´, which transplanted bone marrow to
six persons exposed to high doses of radiation.1 More than
60 years later the hematopoietic stem cell transplantation
still is the only one used in clinical practice. Nevertheless,
cell transplantation approaches are, since then, being exten-
sively investigated for a wide range of diseases/injuries. In
the particular case of spinal cord injuries, a condition that
affect millions all over the world,2 two kinds of transplanted
cells gain ground when compared to the others. Olfactory
ensheathing cells (OECs), obtained from olfactory bulbs or
nasal mucosa, and Schwann Cells (SCs), found in the periph-
eral nervous system, have shown to promote neuronal
repair, remyelination, and functional recovery after trans-
plantation into the spinal cord.3–7 Both cell types are known
to express similar molecular markers, such as p75 and S100
and to display a similar morphological phenotype in cul-
ture.8,9 However, contrasting with SCs, which are largely
involved in myelination and repair of peripheral nerve
ﬁbers, the OECs are known to provide support and guidance
to the growth of newly formed axons from the olfactory
mucosa to the olfactory bulbs. Moreover, they are also
known to be able migrate through the glial scar.10
Recent modest results of clinical trials11,12 emphasize
the need of further studies to understand the mechanism of
action and transplantation of these cells. One of the prob-
lems associated with cell transplantation therapies is cell
survival in vivo, since extensive cell death is usually
observed after transplants.13,14 This fact is mainly related
with the lack of matrix support of transplanted cells, as well
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as the inﬂammation in the local of injury.15 For these
reasons, we propose the delivery of cells within a scaffold
that is not implanted directly in the injury site, thus avoid-
ing the cell death by the lack of matrix support and decreas-
ing the effects of inﬂammation on the fate of transplanted
cells. Hence, within this work, we tested the ability of a pre-
vious developed and characterized natural starch-based
scaffold (SPCL, starch poly-e-caprolactone)16 to support the
3D culture of OECs and SCs. We have previously shown sig-
niﬁcant motor recovery in Spinal cord injury (SCI) animals
due the spine stabilization by using the above-referred scaf-
folds.17 Moreover, it was previously demonstrated that OECs
and SCs are able to secrete neurotrophic factors such as
nerve growth factor, brain-derived neurotrophic factor, and
glia cell line-derived neurotrophic factor.18,19 Additionally,
the secretome of these two cells has previously shown to
have a positive effect on axonal growth both in vitro20–22
and in vivo.23–25 Therefore, the presence of these cells on
the areas of the scaffold, which face the spinal cord, will
allow a localized deliver of neurotrophic factors to the
injured area, fostering regeneration to occur. In this sense,
combining the secretome effects of OECs and SCs with the
previously observed beneﬁcial effects of spine stabilization
provided by the SPCL scaffolds implantation may lead to
further locomotory recovery.
To do so, we ﬁrst need to ﬁgure out if it is possible to
culture OECs and SCs on the SPCL scaffolds. Therefore, in
this report we assessed the proliferation, metabolic activity,
adhesion, morphology, and distribution of primary OECs
and SCs when cultured in a 3D fashion on SPCL scaffolds.
The results revealed that SPCL scaffolds were able to
support the growth and migration of both OECs and SCs.
Moreover, we determined that two weeks of in vitro prein-
cubation is the ideal time to achieve a higher cell density on
these scaffolds.
MATERIALS AND METHODS
Semi tubular SPCL scaffolds development
The SPCL scaffolds were developed as previously reported
by Silva et al.16 Brieﬂy, porous sheets featuring interﬁlament




Tubular scaffolds were obtained by rolling up porous sheets
around a cylinder and subsequent heat treatment at 65C
during 30 min for inducing the adhesion between ﬁlaments.
Two different porous tubular scaffold designs were obtained
featuring a single or double layer, further referred as 90/1
and 90/2 for structures with one or two layers, respectively.
After being processed, to acquire semi tubular form, the
tubular scaffolds were cut in the middle with the aid of
a blade.
Scanning electron microscope (SEM) analyses
Scanning electron microscopy (SEM) was used for analysis
of morphology of the different SPCL tubular scaffolds. For
this purpose, all samples were coated with Au/Pd via ion
sputtering prior to observation in a Stereoscan 360 SEM
(Leica Cambridge, Cambridge, United Kingdom).
Cell culture
Isolation and culture of OECs. OECs were harvested from
olfactory bulbs of 4-days-old Wistar rats, according to the
protocol described by Ramo´n-Cueto and Nieto-Sampedro26
Brieﬂy, upon dissection, all meninges were removed and
the tissue was digested with 0.125% Collagenase (Sigma)
for 20 h at 37C. The digested tissue was mechanically
dissociated with a pipette and then ﬁltrated through a 70
lm cell strainer (BD Falcon). After centrifugation at 1000
rpm for 10 min, cells were resuspended and plated in
uncoated plates for 18 h. A posterior change to uncoated
plates for 36 h was made, as it is expected that most of the
ﬁbroblasts and astrocytes will attach in the ﬁrst and second
period, respectively. Finally, cell suspensions were trans-
ferred to poly-D-lysine treaded ﬂasks and cultured in
DMEM/F12 (Gibco) with 10% of FBS (Gibco) and 1% of
antibiotic-antimycotic solution (Sigma) at 37C and 5% CO2
(v/v). OECs were then enriched by the supplementation
with Bovine Pituitary Extract (5 lg/mL, Gibco) and Forsko-
lin (2 lg/mL, Sigma). Cells were seeded into the scaffolds at
passage 2; being that no trypsin was used and cells were
detached using a cell scrapper.
Isolation and culture of SCs. SCs were obtained from sci-
atic nerves of 4-weeks-old male Wistar rats, according to
the protocol described by Mauritz et al.27 Upon dissection,
sciatic nerves were cut into three fragments each and incu-
bated in DMEM-F-12 (Gibco no.11320-074), with 10% Fetal
Bovine Serum (FBS, Gibco 10106-169), 1% Penicillin-Strep-
tomycin antibiotic (Pen-Strep, Gibco no.15140-148), Forsko-
lin (2 lg/mL, Sigma), and Bovine Pituitary Extract (5 lg/
mL, Gibco). Following 7 days of incubation at 37C and 5%
CO2, the nerve fragments were enzymatically dissociated
with Collagenase solution (320 U/mL; Sigma no. C0130-1G)
containing 5 U/mL of DNase (Worthington Lot 51M5139)
for 20 h. After mechanical dissociation, the collagenase was
removed by repeated centrifugations. Cells were then
allowed to grow in poly-D-lysine coated ﬂasks. As for OECs,
SCs were also seeded into the scaffolds at passage 2.
Immunocytochemistry
Immunostaining was performed as follows. SC or OEC-cov-
ered cover-slips were ﬁxed in 4% paraformaldehyde for
20 min and then washed with PBS. After cell blocking by
treating them with 10% of FCS in PBS (Gibco) for 1 h, Rab-
bit anti-S100 primary antibody (Invitrogen) was incubated
for 1 h. After washing with PBS, cells were exposed to
the secondary antibody Alexa Fluor 488 rabbit anti-rat IgG
(Molecular Probes) for 1 h. Finally, cell nuclei were counter-
stained with DAPI (1 lg/mL, ThermoScientiﬁc) for 5 min
and washed with PBS. Primary antibody was omitted to pro-
duce negative controls. Samples were observed under an
Olympus BX-61 Fluorescence Microscope (Olympus).
Seeding of OECs or SCs on SPCL scaffolds
To ensure adherence of cells, SPCL scaffolds were coated
with poly-L-lysine before cell seeding. Cells were centrifuged
at 1200 rpm for 5 min and then resuspended in a small
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volume of medium to yield a solution with a density of 5 
104 cell/10 lL. Subsequently, scaffolds were transferred to
empty wells and 10 lL of cell suspension were dropped on
the top of the inner lumen of the semi tubular scaffolds. Af-
ter an incubation of 2 h in a humidiﬁed atmosphere at 37C
and 5% CO2, SPCL scaffolds were transferred to new wells
containing complete medium (for composition details refer
to OECs or SCs cell culture section) and incubated for 2, 7,
14, and 21 days for the in vitro assays.
Proliferation evaluation
In the time points mentioned above, proliferation, through
double-stranded DNA quantiﬁcation, was assessed. The ﬂuo-
rescent dye Picogreen was used to acquire the total amount
of dsDNA.28 Brieﬂy, after cell lysis by osmotic and thermal
shock three components of QuantiTTM PicoGreen dsDNA
Assay Kit (Invitrogen), Tris-HCl-EDTA (50%), Picogreen dye
(35.45%), and cell lysated (16.35%), were mixed in an
opaque 96 well plate. The ﬂuorescent intensity, proportional
to the amount of dsDNA, was measured at an excitation
wavelength of 485/20 nm and at an emission wavelength of
528/20 nm, in a microplate reader (Bio-Tek). The dsDNA
concentration for triplicates of each sample (n ¼ 3) was cal-
culated using a standard curve relating quantity of dsDNA
and ﬂuorescence intensity.
Metabolic activity assay
Cell viability was measured using the CellTiter 96V
R
Aqueous
One Solution Cell Proliferation Assay (Promega). This assay
is based on the bioreduction of a tetrazolium compound
(MTS), into a water-soluble brown formazan product. This
conversion is accomplished by NADPH or NADH production
by the dehydrogenase enzymes in metabolically active cells.
Complete culture medium was replaced by standard
DMEM/F12 medium containing MTS in a 5:1 ratio and
incubated in a humidiﬁed atmosphere at 37C and 5% CO2.
After 3 h of incubation, the optic density for triplicates of
each sample (n ¼ 3) was measured at 490 nm in a micro-
plate reader.
Assessment of cell adhesion, morphology,
and distribution
At each deﬁned time culture period, the SPCL scaffolds
were ﬁxed with 4% of paraformaldehyde for 30 min at
room temperature. Then, 0.1 lg/mL of Phalloidin (Sigma)
was added to the cells during 30 min. After washing three
times with PBS, cell nuclei were counterstained with DAPI
(1 lg/mL, ThermoScientiﬁc) for 5 min. The SPCL scaffolds
were then observed by confocal microscopy (Olympus).
Statistical analysis
To assess the statistical differences on metabolic activity
and proliferation of OECs and SCs, a ‘‘two way ANOVA’’ test
was performed followed by a Bonferroni post-test. Statistical
signiﬁcance was deﬁned for p < 0.05.
RESULTS AND DISCUSSION
Ensure cell survival in vivo is one of the problems associ-
ated with cell transplantation therapies, since extensive cell
death is usually observed after transplants.13 The lack of
matrix support, ischemia, and local inﬂammation are some
of the factors related with poor cell survival after cell based
therapies.15 Typical cells preparations for injection imply
enzymatic digestion of the matrix. When cells that normally
grow in attachment are kept in suspension, a pathway of
cell death called anoikis is initiated.29 Anoikis, a Greek word
for homelessness, is described in cell biology as pro-
grammed cell death generated by loss of matrix attach-
ments.30 In addition, it is well known that after SCI ischemia
and inﬂammation occur.31 These two events generate oxy-
gen free radicals and inﬂammatory cytokines that can
directly damage graft cells via cell membrane damage or
trigger signaling pathways that result in caspase activation
and cell death.15 To cell-based regenerative medicine
approaches become a successful therapy, these issues
should be addressed. Okano and coworkers32,33 proposed
the use of cell sheets, avoiding in this way the loss of cell
matrix support. Others targeted speciﬁc molecular pathways
aimed at cell death blockage.34 We consider that the deliv-
ery of cells, with a trophic ability, within a scaffold that is
not implanted directly in the injury will avoid the cell death
by anoikis and decrease the effects of inﬂammation on the
fate of transplanted cells.
We have recently shown that the spine stabilization by
SPCL scaffolds implanted in the vertebral column of SCI rats
lead to signiﬁcant improvements.17 However, the spine
stabilization alone will not successfully treat the injured
animals, and therefore further actions are needed to repair
the spinal cord. Thus, in this work, we investigated the abil-
ity of SPCL scaffolds to support cells aimed for SCI repair.
In this way, the scaffolds will act as a stabilization device
and at same time will allow a localized deliver of neurotro-
phic factors to the injured spinal cord produce by the OECs
or SCs.
3D culture of OECs on SCPL scaffolds
OECs and SCs were analyzed, prior seeding on SPCL scaf-
folds, by immunocytochemistry against S100 receptor
[Fig. 1(a,b)]. Subsequently, cells were seeded in the inner
core of SPCL scaffolds with one layer [90/1, Fig. 1(c)] or
two layers [90/2, Fig. 1(d)]. Cell adhesion, migration, proli-
feration, and metabolic activity were assessed 2, 7, 14, and
21 days after the seeding.
The quantiﬁcation of dsDNA revealed a signiﬁcant
increase of cell proliferation from day 2 to day 21, both on
single and on double layer SPCL scaffolds [Fig. 2(a)]. Fur-
thermore, only at the second day of culture, the quantity of
OECs on single layer scaffolds is signiﬁcantly higher than in
double layer scaffolds, demonstrating a more efﬁcient cell
seeding on 90/1 scaffolds. Interesting, either for 90/1 or for
90/2 scaffolds, the quantity of dsDNA did not increase from
day 2 to 1 week in culture, which indicates that these cells
need a time to adapt to the new 3D surface. Moreover, cells
cultured on single layer scaffolds did not presented
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signiﬁcant cell proliferation between 2 and 3 weeks. On the
contrary, on 90/2 scaffolds dsDNA signiﬁcant increases
between 2 and 3 weeks were observed. These differences
can be explained by the lower porosity of the 90/2 scaf-
folds. We have previously reported differences in the poros-
ity of single and double layer scaffolds, being 90/2 scaffolds
15% less porous than the 90/1 ones.16 Therefore, in this
condition the cells need more time to reach the conﬂuence.
The dsDNA quantiﬁcation results are in concordance with
the measured metabolic activity of OECs [Fig. 2(b)], which
from day 2 to day 21 increased signiﬁcantly on both types
of scaffolds. Moreover and up to 14 days in culture, OECs
seeded on 90/1 scaffolds showed a statistically higher meta-
bolic activity than the ones seeded in 90/2 scaffolds. As
referred before the cell seeding was more efﬁcient on these
scaffolds than on the 90/2 ones, a fact that is closely related
with these observations, as the initial cell densities would
be necessarily different in both. Then, again, the metabolic
activity is signiﬁcantly different between 2 and 3 weeks for
double layer scaffolds but not for single layer.
The assessment of migration, adhesion and morphology
of OECs by confocal microscopy showed a low efﬁciency on
cell seeding [Fig. 2(c,d), 48 h]. However, over time the OECs
successfully colonized the entire SPCL ﬁbers, showing that
these cells are capable to migrate and grow in a 3D manner
on SPCL scaffolds [Fig. 2(c,d)]. Moreover, after 2 weeks, it
was possible to observe the typical spindle-shaped morpho-
logy of OECs, which conﬁrmed how well adapted the cells
were. Finally, it is possible to conﬁrm that in 90/1 scaffolds
cells were conﬂuent at 2 weeks, but for 90/2 the conﬂuence
was only reached at 3 weeks. All of the tests indicated that
OECs culture on SPCL scaffolds with one or two layers
should be implanted in animals after 2 or 3 weeks of
in vitro culture.
3D culture of SCs on SCPL scaffolds
Contrasting with OECs, SCs adapted faster on the rigid 90/2
scaffold than in the more porous 90/1 scaffold. dsDNA
quantiﬁcation test revealed that as OECs, the SCs also signif-
icantly increased the number of cells from day 2 to day 21
in both types of scaffolds [Fig. 3(a)]. Again, as happened
with OECs, the SCs also took around one week to adapt to
the new surface, since no signiﬁcant differences were
detected between 2 days and 1 week of culture. However,
and in contrast to OECs, the quantity of dsDNA on SCs cul-
ture is always higher in the double layer scaffolds, showing
that these cells were better adapted to 90/2 scaffolds. Inter-
estingly, cell proliferation stops at 2 weeks for both types of
scaffolds, indicating that the implantation of SPCL scaffolds
with SCs should be done after around 2 weeks of in vitro
culture. By analyzing the metabolic activity of SCs cultured
on SPCL scaffolds [Fig. 3(b)] it was possible to conﬁrm that
the cells took around 1 week to be adapted to the scaffold
(no differences between 2 days and 1 week). No differences
FIGURE 1. Cells and scaffolds before the 3D cultured. The presence of OECs (a) and SCs (b) after cell isolation was conﬁrmed by immunocyto-
chemistry against S-100 protein (green) and nuclei counterstained with DAPI (blue). OECs and SCs were then seeded on the inner core of single
(c) or double (d) layer SPCL scaffolds. [Color ﬁgure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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were found between weeks 2 and 3, reinforcing the idea
that these cells should only be cultured on the scaffolds for
periods up to two weeks before transplantation. It is sur-
prising, although the absence of signiﬁcant differences
between the one and two layers scaffolds; in other words, it
seems that despite the lower number of cells in the one-
layer scaffolds, they were more metabolically active than the
cells from two layers, a difference that may be due to the
higher porosity of the one-layer scaffolds.
The assessment of migration, adhesion, and morphology
of SCs by confocal microscopy showed a low efﬁcient cell
seeding, particular for single layer scaffolds [Fig. 3(c), 48 h].
However, over time the SCs, as happened with OECs, also
successfully colonized the entire SPCL ﬁbers [Fig. 3(c,d)],
showing that these cells are capable to migrate and grow in
a 3D manner on SPCL scaffolds. Finally, it was possible to
conﬁrm that cells reached the conﬂuence at 2 weeks either
in 90/1 or in 90/2 scaffolds, and there was a decrease in
cell number at 3 weeks. All of the tests indicated that SCs
culture on SPCL scaffolds with one or two layers should be
implanted in animals after 2 weeks of in vitro culture.
The results presented in this work show that OECs and
SCs could successfully grow and fully colonize both single
and double SPCL scaffolds. In fact, in both cases there are
some inconsistencies between the dsDNA assay and the
metabolic activity of the cells. However, it is important to
notice that as previously described by Hutmacher and co-
workers35 the quantiﬁcation of metabolic activity in three
dimensions cultures by MTS test cannot be directly com-
pared with proliferations assays, such as the dsDNA assays.
Actually, while the latter are based on the Picogreen assay,
which is a sensitive test that can be correlated with prolifer-
ation of cells with time, MTS relies only in the capability of
cells to metabolize MTS into a formazan salt, measuring the
metabolic viability. This metabolic viability cannot be
directly compared to cell proliferation as the cells own basal
metabolism may be altered due to different parameters
(such as: porosity, oxygen and nutrients availability, nature
of the substrate where they are growing, etc.) that may or,
may not, affect cell proliferation. Thus, it is possible to
obtain different trends for both assays, which do not neces-
sarily invalidate the results obtained from them, as they do
measure different parameters when cells are growing in 3D
scaffolds. In this sense, the results presented in our work
show, for OECs, that after 3 weeks of culturing the use of
90/1 or 90/2 scaffolds will not signiﬁcantly affect the
FIGURE 2. 3D cell culture of OECs on SPCL scaffolds. A signiﬁcant (p < 0.05) overall increase over time was observed either for (a) dsDNA
quantiﬁcation or (b) MTS test. Cellular adhesion, distribution, and morphology were assessed by cytoplasmic staining with phalloidin (red) and
nuclei counterstained with DAPI (blue), followed by confocal observation. Despite of a low efﬁcient cell seeding (48 h), OECs were able to
migrate and colonize all ﬁbers of both single (c) and double (d) layer SPCL scaffold. Values are shown as mean 6 SEM (n ¼ 3). [Color ﬁgure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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number of the transplanted cells. However, for SCs the
amount of dsDNA is always signiﬁcantly higher in the 90/2
scaffolds than in 90/1 ones. This means that for these cells
it would be better to use the 90/2 scaffolds for implanta-
tion. Concerning the metabolic activity, the results show
some differences in the initial time points analyzed, and the
cells reach the maximum activity after 2/3 weeks of culture.
Only in the last time points, it is possible to obtain similar
results in the metabolic activity assay between single and
double layers scaffolds. However, it is important to notice
that the key time points for transplantation presented here
can only be used for these scaffolds, since, most likely cells
will respond in different ways to different polymers. None-
theless, as happened with the starch-based scaffolds pre-
sented in this work, several others studies had shown either
for OECs or SCs that these cells also need an initial time to
adapt to scaffolds made from different origins.36–39 How-
ever, other studies, in which scaffolds were seeded with
cells and implanted in animals just after a short preincuba-
tion in vitro of 1–2 days suggest the opposite.40–42 Never-
theless, it seems reasonable that the study of how cells
behave on scaffolds should be performed at longer time
points before the in vivo implantation, since the implanta-
tion of a scaffold with a higher number of cells will most
likely result in a higher number of cell survival and in this
way, increase the cells’ related effects on the implanted
tissue.
CONCLUSIONS
Within this work, it was possible to demonstrate for the
ﬁrst time that a starch-based scaffold was able to support
the growth and migration of OECs and SCs. Moreover, we
demonstrated the importance of studying the long time
in vitro incubation periods on the number of cells, which
could be transplanted within the scaffold. For the structures
here in studied, we demonstrated that 2 weeks of culture is
the ideal time to reach a high number of transplantable
cells. Further work will focus on the spine stabilization of
SCI animals using SPCL scaffolds loaded with OECs, SCs, or
a combination of both.
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